SS Innovations International Reports Director and Officer Changes

Ticker: SSII · Form: 8-K · Filed: Aug 22, 2024 · CIK: 1676163

Sentiment: neutral

Topics: management-change, corporate-governance

TL;DR

SS Innovations shakes up board and exec team, effective Aug 20.

AI Summary

SS Innovations International, Inc. (formerly AVRA Medical Robotics, Inc.) filed an 8-K on August 22, 2024, reporting changes effective August 20, 2024. The filing covers the departure of directors, election of new directors, appointment of officers, and details on compensatory arrangements for certain officers. The company is incorporated in Florida and its principal executive offices are located in Fort Lauderdale.

Why It Matters

Changes in board and executive leadership can signal shifts in company strategy, operational focus, or financial direction.

Risk Assessment

Risk Level: medium — Changes in directorship and executive roles can introduce uncertainty regarding future strategy and performance.

Key Players & Entities

FAQ

What specific changes were made regarding directors and officers?

The 8-K filing indicates the departure of directors, the election of new directors, and the appointment of certain officers, along with details on their compensatory arrangements.

When were these changes effective?

The changes reported in the 8-K were effective as of August 20, 2024.

What is the former name of SS Innovations International, Inc.?

The former name of SS Innovations International, Inc. was AVRA Medical Robotics, Inc.

In which state is SS Innovations International, Inc. incorporated?

SS Innovations International, Inc. is incorporated in Florida.

Where are the principal executive offices of the company located?

The principal executive offices of SS Innovations International, Inc. are located at 1600 SE 15th Street, #512, Fort Lauderdale, Florida 33316.

Filing Stats: 1,049 words · 4 min read · ~3 pages · Grade level 10.4 · Accepted 2024-08-22 16:05:25

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 22, 2024 SS INNOVATIONS INTERNATIONAL, INC. By: /s/ Sudhir Srivastava Sudhir Srivastava, M.D. Chairman and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing